Speaker illustration

Mr Gerrit Jan Adriaan Vos

St Antonius Hospital, Nieuwegein (Netherlands (The))

Tailored antiplatelet therapy based on CYP2C19 genotyping: a POPular Genetics pilot study

Event: ESC CONGRESS 2016

Topic: Thrombosis and platelets

Session: Antiplatelet therapy

Thumbnail

Platelet reactivity is gender and age related

Event: ESC CONGRESS 2016

Topic: Thrombosis and platelets

Session: Antiplatelet therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk